Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Neurobiol Learn Mem ; 118: 55-63, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25451306

ABSTRACT

Both egocentric route-based learning and spatial learning, as assessed by the Cincinnati water maze (CWM) and Morris water maze (MWM), respectively, are impaired following an 80% dopamine (DA) loss in the neostriatum after 6-hydroxydopamine (6-OHDA) administration in rats. The dorsolateral striatum (DLS) and the dorsomedial striatum (DMS) are implicated in different navigational learning types, namely the DLS is implicated in egocentric learning while the DMS is implicated in spatial learning. This experiment tested whether selective DA loss through 6-OHDA lesions in the DMS or DLS would impair one or both types of navigation. Both DLS and DMS DA loss significantly impaired route-based CWM learning, without affecting spatial or cued MWM performance. DLS 6-OHDA lesions produced a 75% DA loss in this region, with no changes in other monoamine levels in the DLS or DMS. DMS 6-OHDA lesions produced a 62% DA loss in this region, without affecting other monoamine levels in the DMS or DLS. The results indicate a role for DA in DLS and DMS regions in route-based egocentric but not spatial learning and memory. Spatial learning deficits may require more pervasive monoamine reductions within each region before deficits are exhibited. This is the first study to implicate DLS and DMS DA in route-based egocentric navigation.


Subject(s)
Dopamine/physiology , Maze Learning/physiology , Neostriatum/physiology , Spatial Navigation/physiology , Animals , Biogenic Monoamines/analysis , Biogenic Monoamines/chemical synthesis , Dopamine/chemical synthesis , Male , Maze Learning/drug effects , Neostriatum/chemistry , Oxidopamine/administration & dosage , Rats , Rats, Sprague-Dawley , Spatial Navigation/drug effects
2.
J Urol ; 189(6): 2342-9, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23159277

ABSTRACT

PURPOSE: VGLUTs, which are essential for loading glutamate into synaptic vesicles, are present in various neuronal systems. However, to our knowledge the expression of VGLUTs in neurons innervating the bladder has not yet been analyzed. We studied VGLUT1, VGLUT2 and VGLUT3 in mouse bladder neurons. MATERIALS AND METHODS: We analyzed the expression of VGLUT1, VGLUT2 and calcitonin gene-related peptide by immunohistochemistry in the retrograde labeled primary afferent and autonomic neurons of BALB/c mice after injecting fast blue in the bladder wall. To study VGLUT3 we traced the bladder of transgenic mice, in which VGLUT3 is identified by enhanced green fluorescent protein detection. RESULTS: Most bladder dorsal root ganglion neurons expressed VGLUT2. A smaller percentage of neurons also expressed VGLUT1 or VGLUT3. Co-expression with calcitonin gene-related peptide was only observed for VGLUT2. Occasional VGLUT2 immunoreactive neurons were seen in the major pelvic ganglia. Abundant VGLUT2 immunoreactive nerves were detected in the bladder dome and trigone, and the urethra. VGLUT1 immunoreactive nerves were discretely present. CONCLUSIONS: We present what are to our knowledge novel data on VGLUT expression in sensory and autonomic neurons innervating the mouse bladder. The frequent association of VGLUT2 and calcitonin gene-related peptide in sensory neurons suggests interactions between glutamatergic and peptidergic neurotransmissions, potentially influencing commonly perceived sensations in the bladder, such as discomfort and pain.


Subject(s)
Calcitonin Gene-Related Peptide/metabolism , Ganglia, Spinal/metabolism , Urinary Bladder/innervation , Vesicular Glutamate Transport Proteins/metabolism , Animals , Autonomic Nervous System/physiology , Calcitonin Gene-Related Peptide/genetics , Fluorescent Antibody Technique , Gene Expression Regulation , Immunohistochemistry , Male , Mice , Mice, Inbred BALB C , Models, Animal , Neurons, Afferent/metabolism , Neurons, Afferent/physiology , Sensitivity and Specificity , Sensory Receptor Cells/metabolism , Sensory Receptor Cells/physiology , Urinary Bladder/metabolism , Vesicular Glutamate Transport Proteins/genetics
3.
J Mol Neurosci ; 70(1): 102-111, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31520365

ABSTRACT

The lack of cerebral creatine (Cr) causes intellectual disability and epilepsy. In addition, a significant portion of individuals with Cr transporter (Crt) deficiency (CTD), the leading cause of cerebral Cr deficiency syndromes (CCDS), are diagnosed with attention-deficit hyperactivity disorder. While the neurological effects of CTD are clear, the mechanisms that underlie these deficits are unknown. Part of this is due to the heterogenous nature of the brain and the unique metabolic demands of specific neuronal systems. Of particular interest related to Cr physiology are dopaminergic neurons, as many CCDS patients have ADHD and Cr has been implicated in dopamine-associated neurodegenerative disorders, such as Parkinson's and Huntington's diseases. The purpose of this study was to examine the effect of a loss of the Slc6a8 (Crt) gene in dopamine transporter (Slc6a3; DAT) expressing cells on locomotor activity and motor function as the mice age. Floxed Slc6a8 (Slc6a8flox) mice were mated to DATIREScre expressing mice to generate DAT-specific Slc6a8 knockouts (dCrt-/y). Locomotor activity, spontaneous activity, and performance in the challenging beam test were evaluated monthly in dCrt-/y and control (Slc6a8flox) mice from 3 to 12 months of age. dCrt-/y mice were hyperactive compared with controls throughout testing. In addition, dCrt-/y mice showed increased rearing and hindlimb steps in the spontaneous activity test. Latency to cross the narrow bridge was increased in dCrt-/y mice while foot slips were unchanged. Taken together, these data suggest that the lack of Cr in dopaminergic neurons causes hyperactivity while sparing motor function.


Subject(s)
Brain Diseases, Metabolic, Inborn/genetics , Creatine/deficiency , Dopaminergic Neurons/metabolism , Locomotion , Membrane Transport Proteins/genetics , Mental Retardation, X-Linked/genetics , Plasma Membrane Neurotransmitter Transport Proteins/deficiency , Animals , Brain Diseases, Metabolic, Inborn/physiopathology , Creatine/genetics , Gene Deletion , Male , Membrane Transport Proteins/metabolism , Mental Retardation, X-Linked/physiopathology , Mice , Mice, Inbred C57BL , Plasma Membrane Neurotransmitter Transport Proteins/genetics
4.
ACS Chem Neurosci ; 11(17): 2602-2614, 2020 09 02.
Article in English | MEDLINE | ID: mdl-32697906

ABSTRACT

Studies in mouse, and to a lesser extent in rat, have revealed the neuroanatomical distribution of vesicular glutamate transporters (VGLUTs) and begun exposing the critical role of VGLUT2 and VGLUT3 in pain transmission. In the present study in rat, we used specific riboprobes to characterize the transcript expression of all three VGLUTs in lumbar dorsal root ganglia (DRGs) and in the thoracolumbar, lumbar, and sacral spinal cord. We show for the first time in rat a very discrete VGLUT3 expression in DRGs and in deep layers of the dorsal horn. We confirm the abundant expression of VGLUT2, in both DRGs and the spinal cord, including presumable motorneurons in the latter. As expected, VGLUT1 was present in many DRG neuron profiles, and in the spinal cord it was mostly localized to neurons in the dorsal nucleus of Clarke. In rats with a 10 day long hindpaw inflammation, increased spinal expression of VGLUT2 transcript was detected by qRT-PCR, and intrathecal administration of the nonselective VGLUT inhibitor Chicago Sky Blue 6B resulted in reduced mechanical and thermal allodynia for up to 24 h. In conclusion, our results provide a collective characterization of VGLUTs in rat DRGs and the spinal cord, demonstrate increased spinal expression of VGLUT2 during chronic peripheral inflammation, and support the use of spinal VGLUT blockade as a strategy for attenuating inflammatory pain.


Subject(s)
Ganglia, Spinal , Vesicular Glutamate Transport Proteins , Animals , Inflammation , Mice , Neurons , Rats , Spinal Cord , Vesicular Glutamate Transport Protein 1/genetics , Vesicular Glutamate Transport Protein 2/genetics , Vesicular Glutamate Transport Proteins/genetics
5.
Neurotox Res ; 30(2): 199-212, 2016 08.
Article in English | MEDLINE | ID: mdl-27003940

ABSTRACT

The nucleus accumbens (Nacc) and medial prefrontal cortex (mPFC) receive dopaminergic innervation from the ventral tegmental area and are involved in learning. Male rats with 6-hydroxydopamine (6-OHDA)-induced dopaminergic and noradrenergic reductions in the Nacc or mPFC were tested for allocentric and egocentric learning to determine their role in these forms of neuroplasticity. mPFC dopaminergic and noradrenergic reductions did not result in changes to either type of learning or memory. Nacc dopaminergic and noradrenergic reductions resulted in allocentric learning and memory deficits in the Morris water maze (MWM) on acquisition, reversal, and probe trials. MWM cued performance was also affected, but straight-channel swim times and swim speed during hidden platform trials in the MWM were not affected. Nacc dopaminergic and noradrenergic reductions also impaired egocentric learning in the Cincinnati water maze (CWM). Nacc-lesioned animals tested in the CWM in an alternate path through the maze were not significantly affected. 6-OHDA injections in the Nacc resulted in 63 % dopamine and 62 % norepinephrine reductions in the Nacc and 23 % reductions in adjacent dorsal striatum. 6-OHDA injections in the mPFC resulted in 88 % reductions in dopamine and 59 % reductions in norepinephrine. Hence, Nacc dopamine and/or norepinephrine play a role in egocentric and allocentric learning and memory, while mPFC dopamine and norepinephrine do not.


Subject(s)
Dopamine/deficiency , Maze Learning/physiology , Nucleus Accumbens/metabolism , Oxidopamine/toxicity , Prefrontal Cortex/metabolism , Spatial Navigation/physiology , Animals , Cohort Studies , Learning Disabilities/metabolism , Male , Memory Disorders/metabolism , Models, Animal , Random Allocation , Rats, Sprague-Dawley , Spatial Memory/physiology
6.
Schizophr Res ; 171(1-3): 195-9, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26830319

ABSTRACT

Activation of the maternal innate immune system, termed "maternal immune activation" (MIA), represents a common environmental risk factor for schizophrenia. Whereas evidence suggests dysregulation of GABA systems may underlie the pathophysiology of schizophrenia, a role for MIA in alteration of GABAergic systems is less clear. Here, pregnant rats received either the viral mimetic polyriboinosinic-polyribocytidilic acid or vehicle injection on gestational day 14. Glutamic acid decarboxylase-67 (GAD67) mRNA expression was examined in male offspring at postnatal day (P)14, P30 and P60. At P60, GAD67 mRNA was elevated in hippocampus and thalamus and decreased in prefrontal cortex of MIA offspring. MIA-induced alterations in GAD expression could contribute to the pathophysiology of schizophrenia.


Subject(s)
Brain/enzymology , Gene Expression Regulation, Enzymologic/physiology , Glutamate Decarboxylase/metabolism , Prenatal Exposure Delayed Effects/pathology , Age Factors , Animals , Animals, Newborn , Autoradiography , Disease Models, Animal , Female , Gene Expression Regulation, Enzymologic/drug effects , Glutamate Decarboxylase/genetics , Interferon Inducers/toxicity , Male , Poly I-C/toxicity , Pregnancy , Prenatal Exposure Delayed Effects/chemically induced , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley
7.
Physiol Behav ; 146: 7-15, 2015 Jul 01.
Article in English | MEDLINE | ID: mdl-26066725

ABSTRACT

Chronic social subordination is a well-known precipitant of numerous psychiatric and physiological health concerns. In this study, we examine the effects of chronic social stress in the visible burrow system (VBS) on the expression of glutamic acid decarboxylase (GAD) 67 and brain-derived neurotropic factor (BDNF) mRNA in forebrain stress circuitry. Male rats in the VBS system form a dominance hierarchy, whereby subordinate males exhibit neuroendocrine and physiological profiles characteristic of chronic exposure to stress. We found that social subordination decreases GAD67 mRNA in the peri-paraventricular nucleus region of the hypothalamus and the interfascicular nucleus of the bed nucleus of the stria terminalis (BNST), and increases in GAD67 mRNA in the hippocampus, medial prefrontal cortex, and dorsal medial hypothalamus. Expression of BDNF mRNA increased in the dorsal region of the BNST, but remained unchanged in all other regions examined. Results from this study indicate that social subordination is associated with several region-specific alterations in GAD67 mRNA expression in central stress circuits, whereas changes in the expression of BDNF mRNA are limited to the BNST.


Subject(s)
Brain/metabolism , Gene Expression Regulation/physiology , Glutamate Decarboxylase/genetics , RNA, Messenger/metabolism , Stress, Psychological/pathology , Analysis of Variance , Animals , Body Composition/physiology , Body Weight/physiology , Brain-Derived Neurotrophic Factor/genetics , Brain-Derived Neurotrophic Factor/metabolism , Corticosterone/blood , Disease Models, Animal , Female , Glutamate Decarboxylase/metabolism , Male , Radioimmunoassay , Rats , Rats, Long-Evans , Social Behavior , Time Factors
8.
Schizophr Res ; 168(1-2): 411-20, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26206493

ABSTRACT

Maternal immune activation (MIA) is an environmental risk factor for schizophrenia, and may contribute to other developmental disorders including autism and epilepsy. Activation of pro-inflammatory cytokine systems by injection of the synthetic double-stranded RNA polyriboinosinic-polyribocytidilic acid (Poly I:C) mediates important neurochemical and behavioral corollaries of MIA, which have relevance to deficits observed in schizophrenia. We examined the consequences of MIA on forebrain expression of neuregulin-1 (NRG-1), brain-derived neurotrophic factor (BDNF) and their receptors, ErbB4 and trkB, respectively, genes associated with schizophrenia. On gestational day 14, pregnant rats were injected with Poly I:C or vehicle. Utilizing in situ hybridization, expression of NRG-1, ErbB4, BDNF, and trkB was examined in male rat offspring at postnatal day (P) 14, P30 and P60. ErbB4 mRNA expression was significantly increased at P30 in the anterior cingulate (AC Ctx), frontal, and parietal cortices, with increases in AC Ctx expression continuing through P60. ErbB4 expression was also elevated in the prefrontal cortex (PFC) at P14. In contrast, NRG-1 mRNA was decreased in the PFC at P60. Expression of BDNF mRNA was significantly upregulated in the PFC at P60 and decreased in the AC Ctx at P14. Expression of trkB was increased in two regions, the piriform cortex at P14 and the striatum at P60. These findings demonstrate developmentally and regionally selective alterations in the expression of schizophrenia-related genes as a consequence of MIA. Further study is needed to determine contributions of these effects to the development of alterations of relevance to neuropsychiatric diseases.


Subject(s)
Brain-Derived Neurotrophic Factor/metabolism , Gene Expression Regulation, Developmental/physiology , Neuregulin-1/metabolism , Prenatal Exposure Delayed Effects/pathology , Prosencephalon/metabolism , Receptor, ErbB-4/metabolism , Receptor, trkB/metabolism , Age Factors , Animals , Brain-Derived Neurotrophic Factor/genetics , Female , Gene Expression Regulation, Developmental/drug effects , Interferon Inducers/toxicity , Male , Neuregulin-1/genetics , Poly I-C/toxicity , Pregnancy , Prenatal Exposure Delayed Effects/chemically induced , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Receptor, ErbB-4/genetics , Receptor, trkB/genetics
9.
Exp Neurol ; 230(2): 258-72, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21596036

ABSTRACT

Glutamate is the main excitatory neurotransmitter in the nervous system, including in primary afferent neurons. However, to date a glutamatergic phenotype of autonomic neurons has not been described. Therefore, we explored the expression of vesicular glutamate transporter (VGLUT) types 1, 2 and 3 in lumbar sympathetic chain (LSC) and major pelvic ganglion (MPG) of naïve BALB/C mice, as well as after pelvic nerve axotomy (PNA), using immunohistochemistry and in situ hybridization. Colocalization with activating transcription factor-3 (ATF-3), tyrosine hydroxylase (TH), vesicular acetylcholine transporter (VAChT) and calcitonin gene-related peptide was also examined. Sham-PNA, sciatic nerve axotomy (SNA) or naïve mice were included. In naïve mice, VGLUT(2)-like immunoreactivity (LI) was only detected in fibers and varicosities in LSC and MPG; no ATF-3-immunoreactive (IR) neurons were visible. In contrast, PNA induced upregulation of VGLUT(2) protein and transcript, as well as of ATF-3-LI in subpopulations of LSC neurons. Interestingly, VGLUT(2)-IR LSC neurons coexpressed ATF-3, and often lacked the noradrenergic marker TH. SNA only increased VGLUT(2) protein and transcript in scattered LSC neurons. Neither PNA nor SNA upregulated VGLUT(2) in MPG neurons. We also found perineuronal baskets immunoreactive either for VGLUT(2) or the acetylcholinergic marker VAChT in non-PNA MPGs, usually around TH-IR neurons. VGLUT(1)-LI was restricted to some varicosities in MPGs, was absent in LSCs, and remained largely unaffected by PNA or SNA. This was confirmed by the lack of expression of VGLUT(1) or VGLUT(3) mRNAs in LSCs, even after PNA or SNA. Taken together, axotomy of visceral and non-visceral nerves results in a glutamatergic phenotype of some LSC neurons. In addition, we show previously non-described MPG perineuronal glutamatergic baskets.


Subject(s)
Glutamic Acid/metabolism , Neurons/metabolism , Sciatic Nerve/metabolism , Vesicular Glutamate Transport Protein 2/metabolism , Activating Transcription Factor 3/metabolism , Animals , Axotomy , Ganglia, Spinal/metabolism , Immunohistochemistry , In Situ Hybridization , Mice , Sciatic Nerve/surgery , Tyrosine 3-Monooxygenase/metabolism
10.
J Comp Neurol ; 519(16): 3346-66, 2011 Nov 01.
Article in English | MEDLINE | ID: mdl-21800314

ABSTRACT

Vesicular glutamate transporters (VGLUTs) have been extensively studied in various neuronal systems, but their expression in visceral sensory and autonomic neurons remains to be analyzed in detail. Here we studied VGLUTs type 1 and 2 (VGLUT(1) and VGLUT(2) , respectively) in neurons innervating the mouse colorectum. Lumbosacral and thoracolumbar dorsal root ganglion (DRG), lumbar sympathetic chain (LSC), and major pelvic ganglion (MPG) neurons innervating the colorectum of BALB/C mice were retrogradely traced with Fast Blue, dissected, and processed for immunohistochemistry. Tissue from additional naïve mice was included. Previously characterized antibodies against VGLUT(1) , VGLUT(2) , and calcitonin gene-related peptide (CGRP) were used. Riboprobe in situ hybridization, using probes against VGLUT(1) and VGLUT(2) , was also performed. Most colorectal DRG neurons expressed VGLUT(2) and often colocalized with CGRP. A smaller percentage of neurons expressed VGLUT(1) . VGLUT(2) -immunoreactive (IR) neurons in the MPG were rare. Abundant VGLUT(2) -IR nerves were detected in all layers of the colorectum; VGLUT(1) -IR nerves were sparse. A subpopulation of myenteric plexus neurons expressed VGLUT2 protein and mRNA, but VGLUT1 mRNA was undetectable. In conclusion, we show 1) that most colorectal DRG neurons express VGLUT(2) , and to a lesser extent, VGLUT(1) ; 2) abundance of VGLUT2-IR fibers innervating colorectum; and 3) a subpopulation of myenteric plexus neurons expressing VGLUT(2). Altogether, our data suggests a role for VGLUT(2) in colorectal glutamatergic neurotransmission, potentially influencing colorectal sensitivity and motility.


Subject(s)
Colon/metabolism , Myenteric Plexus/metabolism , Rectum/metabolism , Sensory Receptor Cells/metabolism , Vesicular Glutamate Transport Protein 1/biosynthesis , Vesicular Glutamate Transport Protein 2/biosynthesis , Animals , Colon/innervation , Ganglia, Spinal/metabolism , Immunohistochemistry , In Situ Hybridization , Male , Mice , Mice, Inbred BALB C , Rectum/innervation
11.
J Neurochem ; 91(6): 1358-68, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15584912

ABSTRACT

Glial growth factor-2 (GGF2) and other neuregulin (NRG) isoforms have been shown to play important roles in survival, migration, and differentiation of certain neural and non-neural cells. Because midbrain dopamine (DA) cells express the NRG receptor, ErbB4, the present study examined the potential neurotrophic and/or neuroprotective effects of GGF2 on cultured primary dopaminergic neurons. Embryonic day 14 rat mesencephalic cell cultures were maintained in serum-free medium and treated with GGF2 or vehicle. The number of tyrosine hydroxylase-positive (TH+) neurons and high-affinity [3H]DA uptake were assessed at day in vitro (DIV) 9. Separate midbrain cultures were treated with 100 ng/mL GGF2 on DIV 0 and exposed to the catecholamine-specific neurotoxin 6-hydroxydopamine (6-OHDA) on DIV 4. GGF2 treatment significantly increased DA uptake, the number of TH+ neurons, and neurite outgrowth when compared to the controls in both the serum-free and the 6-OHDA-challenged cultures. Furthermore, three NRG receptors were detected in the midbrain cultures by western blot analysis. Immunostaining for glial fibrillary acidic protein revealed that GGF2 also weakly promoted mesencephalic glial proliferation in the midbrain cultures. These results indicate that GGF2 is neurotrophic and neuroprotective for developing dopaminergic neurons and suggest a role for NRGs in repair of the damaged nigrostriatal system that occurs in Parkinson's disease.


Subject(s)
Dopamine/metabolism , Mesencephalon/drug effects , Mesencephalon/metabolism , Nerve Tissue Proteins/pharmacology , Neurons/drug effects , Neurons/metabolism , Neuroprotective Agents/pharmacology , Animals , Cell Survival/drug effects , Cells, Cultured , Culture Media, Serum-Free , Embryo, Mammalian , Humans , Mesencephalon/cytology , Mesencephalon/physiology , Neuregulin-1 , Neurites/drug effects , Neurites/physiology , Neuroglia/drug effects , Neurons/physiology , Oxidopamine/pharmacology , Rats , Rats, Sprague-Dawley , Recombinant Proteins/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL